Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
6.15
-0.19 (-3.00%)
At close: Jul 30, 2025, 4:00 PM
6.00
-0.15 (-2.44%)
After-hours: Jul 30, 2025, 7:44 PM EDT

Passage Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
Selling, General & Admin
24.5624.9941.5845.5460.0630.11
Upgrade
Research & Development
36.3840.1861.4283.75117.6781.79
Upgrade
Operating Expenses
60.9465.17103129.29177.73111.9
Upgrade
Operating Income
-60.94-65.17-103-129.29-177.73-111.9
Upgrade
Interest & Investment Income
3.74.35.62.33.121.3
Upgrade
Other Non Operating Income (Expenses)
1.651.330.73-0.03--
Upgrade
EBT Excluding Unusual Items
-55.59-59.53-96.67-127.03-174.61-110.6
Upgrade
Merger & Restructuring Charges
----6.1--
Upgrade
Gain (Loss) on Sale of Investments
-----2.78-0.63
Upgrade
Asset Writedown
-7.87-5.23-5.39---
Upgrade
Pretax Income
-63.46-64.77-102.06-136.13-185.39-112.23
Upgrade
Net Income
-63.46-64.77-102.06-136.13-185.39-112.23
Upgrade
Net Income to Common
-63.46-64.77-102.06-136.13-185.39-112.23
Upgrade
Shares Outstanding (Basic)
333332
Upgrade
Shares Outstanding (Diluted)
333332
Upgrade
Shares Change (YoY)
12.14%10.34%0.58%2.03%38.14%811.60%
Upgrade
EPS (Basic)
-20.52-21.44-37.29-50.02-69.51-58.13
Upgrade
EPS (Diluted)
-20.52-21.44-37.29-50.02-69.51-58.20
Upgrade
Free Cash Flow
-42.91-47.99-78.41-120.48-144.52-81.67
Upgrade
Free Cash Flow Per Share
-13.87-15.89-28.65-44.27-54.19-42.30
Upgrade
EBITDA
-58.46-62.09-99.28-125.62-176.19-111.1
Upgrade
D&A For EBITDA
2.483.083.723.681.540.8
Upgrade
EBIT
-60.94-65.17-103-129.29-177.73-111.9
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q